Landmark Renal Trials
MOHAMMAD RABIUL I RONY
Landmark Renal Trials & Guidelines is a comprehensive clinical reference for nephrologists, renal trainees, and kidney health professionals. TRIALS Browse 193 landmark clinical trials across 21 categories including CKD progression, SGLT2 inhibitors, glomerular disease, dialysis, transplantation, hypertension, IgA nephropathy, ANCA vasculitis, lupus nephritis, and more. Each trial includes the full name, population, intervention, primary outcome, key results with effect sizes, and the guidelines it informed. GUIDELINES Access 92 clinical practice guidelines from 6 major organisations: • KDIGO — International guidelines covering CKD, glomerular disease, AKI, transplant, diabetes, anaemia, and lipids • UKKA — UK Kidney Association guidelines across CKD, glomerular disease, and dialysis • ISPD — Peritoneal dialysis adequacy and infection guidelines • BTS/NHSBT — UK transplant assessment and management • ABCD — Diabetes and CKD joint guidelines • KDOQI — Vascular access, haemodialysis, peritoneal dialysis, and nutrition FEATURES • Instant full-text search across all trials and guidelines simultaneously • Key recommendations with evidence grades (1A, 1B, 2C, NG) • Trial-to-guideline linkage — see which trials informed each guideline • Works fully offline • Regularly updated with new trials and guideline revisions Designed and curated by a practising nephrologist for everyday clinical use and exam preparation. For educational and clinical reference purposes only. Always verify recommendations against current guidelines and local formulary. Clinical judgement and patient-specific factors must guide all management decisions.